Charles A. Rowland, Jr. has been appointed executive vice president, chief financial officer and treasurer, Endo Pharmaceuticals Holdings, Inc. Mr. Rowland has more than 20 years of pharmaceutical industry experience, including senior-level positions at Pharmacia Corp., Novartis, Bristol-Myers Squibb and most recently as senior vice president and chief financial officer of Biovail Pharmaceuticals. In his new role, he will be responsible for all aspects of Endo’s financial and accounting op...